Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Izcargo approved in Japan for the treatment of MPS II

March 24, 2021

FDA approves Zegalogue to treat severe hypoglycemia in children and adults with diabetes

March 23, 2021

Tildacerfont: 12-week extension study data presented in patients with CAH

March 23, 2021

SOV-2012-F1, oral testosterone formulation that improves patient satisfaction scores

March 23, 2021

Encouraging preliminary phase I data for RP-L301 in pyruvate kinase deficiency

March 23, 2021

AZP-3601 shows promising preliminary data in healthy male subjects

March 22, 2021

Enrollment opens in first-in-human study of mRNA-3927 for propionic acidemia

March 22, 2021

Dual labeling study finds no evidence of pancreatic beta cell neogenesis

March 19, 2021

High blood fats, sugars alter antigen processing

March 18, 2021

VX-880 enters phase I/II trial for type 1 diabetes

March 12, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.